Search Results
Update on immunotherapy trials for AML from ASH 2017: bispecific DARTs, CAR T-cells and ADCs
ASH 2017 highlights: Cell therapy approaches in ALL
ASH 2017 update on progress with novel AML treatments at MD Anderson
Immunotherapy discussions at ASH 2017
Examining the Current Role of CAR T-Cell Therapy in Acute Myeloid Leukemia
Update on venetoclax combination trials for elderly AML from ASH 2017
Update in T-cell recruiting antibody constructs for the treatment of AML
ASH 2017 President’s meeting highlights
An update on the state-of-affairs of BiTEs in the world of AML
Anti-BCMA CAR T-cells for MM: durable clinical responses with ide-cel (formerly bb2121)
The practical challenges of using novel CAR T-cell agents
Bispecific agents: the future of AML and MDS treatment?
